The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Gemcitabine HCL Market Report By Type (Branded, Generic), By Application (Pancreatic Cancer, Breast Cancer, Ovarian Cancer, Non-small Cell Lung Carcinoma (NSCLC), Others), By End-user (Hospitals, Cancer Centers, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11219554
November 2022
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Gemcitabine HCL Market is presumed to reach the market size of nearly USD 1326.63 MN by 2028 from USD 735.1 MN in 2021 with a CAGR of 8.8% under the study period 2022 - 2028.
Gemcitabine HCL is an anticancer drug. It is used to treat cancer of the pancreas, lung, breast, and stomach.It can be taken intravenously or orally. Gemcitabine HCL has been shown to be effective against cancer cells in both laboratory and clinical settings. It is a chemotherapy drug that stops cancer cell growth and can be combined with other medications.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gemcitabine hcl. The growth and trends of gemcitabine hcl industry provide a holistic approach to this study.
By Type
By Application
By End-User
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gemcitabine hcl market include Accord Healthcare, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Fresenius SE & Co. KGaA, Pfizer Inc., Eli Lilly and Company, Ingenus Pharmaceuticals LLC., Cornerstone Pharmaceuticals Inc., ADC Therapeutics SA, Hikma Pharmaceuticals plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Gemcitabine HCL is an anticancer drug. It is used to treat cancer of the pancreas, lung, breast, and stomach.It can be taken intravenously or orally. Gemcitabine HCL has been shown to be effective against cancer cells in both laboratory and clinical settings. It is a chemotherapy drug that stops cancer cell growth and can be combined with other medications.
Market Dynamics
Gemcitabine HCL Market is driven by the high incidence rate of pancreatic cancer, coupled with increasing demand for Gemcitabine HCL from emerging markets such as India and China.The global incidence of cancer continues to rise and is estimated that there will be 22 million new cases diagnosed every year by 2035. In addition, there are more than 50 novel anti-cancer drugs currently under development with many expected to enter clinical trials over the next few years.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gemcitabine hcl. The growth and trends of gemcitabine hcl industry provide a holistic approach to this study.
Market Segmentation
This section of the gemcitabine hcl market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Type
- Branded
- Generic
By Application
- Pancreatic Cancer
- Breast Cancer
- Ovarian Cancer
- Non-Small Cell Lung Carcinoma (NSCLC)
- Others
By End-User
- Hospitals
- Cancer Centers
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Gemcitabine HCL market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Global Gemcitabine HCL Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gemcitabine hcl market include Accord Healthcare, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Fresenius SE & Co. KGaA, Pfizer Inc., Eli Lilly and Company, Ingenus Pharmaceuticals LLC., Cornerstone Pharmaceuticals Inc., ADC Therapeutics SA, Hikma Pharmaceuticals plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
Frequently Asked Questions (FAQs) about this Report
b. For the year 2021, the global market size for gemcitabine HCL was valued at USD 735.1 Million.
b. The global gemcitabine HCL market growth is estimated to be close to 8.8% between 2023 and 2028.
b. In the global gemcitabine HCL market, North America holds the largest market share.
b. The global gemcitabine HCL market is segmented by Type (Branded, Generic), by Application (Pancreatic Cancer, Breast Cancer, Ovarian Cancer, Non-small Cell Lung Carcinoma (NSCLC), Others), by End-user (Hospitals, Cancer Centers, Others).
b. The leading players in the global gemcitabine HCL market are Accord Healthcare, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Fresenius SE & Co. KGaA, Pfizer Inc., Eli Lilly and Company, Ingenus Pharmaceuticals LLC., Cornerstone Pharmaceuticals Inc., ADC Therapeutics SA, Hikma Pharmaceuticals plc.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . GEMCITABINE HCL – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-user
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL GEMCITABINE HCL MARKET ANALYSIS BY TYPE
6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Branded Historic and Forecast Sales by Regions
6.5 Generic Historic and Forecast Sales by Regions
7 . GLOBAL GEMCITABINE HCL MARKET ANALYSIS BY APPLICATION
7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Pancreatic Cancer Historic and Forecast Sales by Regions
7.5 Breast Cancer Historic and Forecast Sales by Regions
7.6 Ovarian Cancer Historic and Forecast Sales by Regions
7.7 Non-small Cell Lung Carcinoma (NSCLC) Historic and Forecast Sales by Regions
7.8 Others Historic and Forecast Sales by Regions
8 . GLOBAL GEMCITABINE HCL MARKET SALES ANALYSIS BY END-USER
8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Cancer Centers Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions
9 . GLOBAL GEMCITABINE HCL MARKET SALES ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
9.3.1. Overview, Historic and Forecast Sales Analysis
9.3.2. North America By Segment Sales Analysis
9.3.3. North America By Country Sales Analysis
9.3.4. United State Sales Analysis
9.3.5. Canada Sales Analysis
9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1. Overview, Historic and Forecast Sales Analysis
9.4.2. Europe by Segment Sales Analysis
9.4.3. Europe by Country Sales Analysis
9.4.4. United Kingdom Sales Analysis
9.4.5. France Sales Analysis
9.4.6. Germany Sales Analysis
9.4.7. Italy Sales Analysis
9.4.8. Russia Sales Analysis
9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1. Overview, Historic and Forecast Sales Analysis
9.5.2. Asia Pacific by Segment Sales Analysis
9.5.3. Asia Pacific by Country Sales Analysis
9.5.4. China Sales Analysis
9.5.5. India Sales Analysis
9.5.6. Japan Sales Analysis
9.5.7. South Korea Sales Analysis
9.5.8. Australia Sales Analysis
9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1. Overview, Historic and Forecast Sales Analysis
9.6.2. Latin America by Segment Sales Analysis
9.6.3. Latin America by Country Sales Analysis
9.6.4. Brazil Sales Analysis
9.6.5. Argentina Sales Analysis
9.6.6. Peru Sales Analysis
9.6.7. Chile Sales Analysis
9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1. Overview, Historic and Forecast Sales Analysis
9.7.2. Middle East & Africa by Segment Sales Analysis
9.7.3. Middle East & Africa by Country Sales Analysis
9.7.4. Saudi Arabia Sales Analysis
9.7.5. UAE Sales Analysis
9.7.6. Israel Sales Analysis
9.7.7. South Africa Sales Analysis
9.7.8. Rest Of Middle East And Africa Sales Analysis
10 . COMPETITIVE LANDSCAPE OF THE GEMCITABINE HCL COMPANIES
10.1. Gemcitabine Hcl Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF GEMCITABINE HCL INDUSTRY
11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Accord Healthcare
11.3.1. Company Overview
11.3.2. Company Revenue
11.3.3. Products
11.3.4. Recent Developments
11.4. Teva Pharmaceutical Industries Ltd.
11.4.1. Company Overview
11.4.2. Company Revenue
11.4.3. Products
11.4.4. Recent Developments
11.5. Dr. Reddy's Laboratories Ltd.
11.5.1. Company Overview
11.5.2. Company Revenue
11.5.3. Products
11.5.4. Recent Developments
11.6. Sun Pharmaceutical Industries Ltd.
11.6.1. Company Overview
11.6.2. Company Revenue
11.6.3. Products
11.6.4. Recent Developments
11.7. Mylan N.V.
11.7.1. Company Overview
11.7.2. Company Revenue
11.7.3. Products
11.7.4. Recent Developments
11.8. Fresenius SE & Co. KGaA
11.8.1. Company Overview
11.8.2. Company Revenue
11.8.3. Products
11.8.4. Recent Developments
11.9. Pfizer Inc.
11.9.1. Company Overview
11.9.2. Company Revenue
11.9.3. Products
11.9.4. Recent Developments
11.10. Eli Lilly and Company
11.10.1. Company Overview
11.10.2. Company Revenue
11.10.3. Products
11.10.4. Recent Developments
11.11. Ingenus Pharmaceuticals LLC.
11.11.1. Company Overview
11.11.2. Company Revenue
11.11.3. Products
11.11.4. Recent Developments
11.12. Cornerstone Pharmaceuticals Inc.
11.12.1. Company Overview
11.12.2. Company Revenue
11.12.3. Products
11.12.4. Recent Developments
11.13. ADC Therapeutics SA
11.13.1. Company Overview
11.13.2. Company Revenue
11.13.3. Products
11.13.4. Recent Developments
11.14. Hikma Pharmaceuticals plc
11.14.1. Company Overview
11.14.2. Company Revenue
11.14.3. Products
11.14.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Type (USD MN)
- Branded Market Sales by Geography (USD MN)
- Generic Market Sales by Geography (USD MN)
- Analysis Market by Application (USD MN)
- Pancreatic Cancer Market Sales by Geography (USD MN)
- Breast Cancer Market Sales by Geography (USD MN)
- Ovarian Cancer Market Sales by Geography (USD MN)
- Non-small Cell Lung Carcinoma (NSCLC) Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by End-user (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Cancer Centers Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Gemcitabine Hcl Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Gemcitabine Hcl Report
- Market Research Process
- Market Research Methodology
- Global Gemcitabine Hcl Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End-user
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Type (USD MN)
- Branded Market Sales by Geography (USD MN)
- Generic Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Pancreatic Cancer Market Sales by Geography (USD MN)
- Breast Cancer Market Sales by Geography (USD MN)
- Ovarian Cancer Market Sales by Geography (USD MN)
- Non-small Cell Lung Carcinoma (NSCLC) Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End-user (USD MN)
- Hospitals Market Sales by Geography (USD MN)
- Cancer Centers Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Pharmaceuticals
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments